Onco-Innovations Ltd. ( (TSE:ONCO) ) has issued an announcement.
Onco-Innovations Limited has successfully closed a non-brokered private placement, raising $600,000 through the issuance of 400,000 units at $1.50 per unit. The funds will support the company’s operational and research objectives, enhancing its position in the oncology sector. The issued securities are subject to a statutory hold period, and the transaction highlights Onco-Innovations’ commitment to advancing cancer treatment technologies.
More about Onco-Innovations Ltd.
Onco-Innovations is a Canadian-based company specializing in oncology, focusing on cancer research and treatment. The company aims to prevent and cure cancer through pioneering research and innovative solutions, with an exclusive worldwide license to patented technology targeting solid tumors.
YTD Price Performance: 69.41%
Average Trading Volume: 273,527
Find detailed analytics on ONCO stock on TipRanks’ Stock Analysis page.